Literature DB >> 10916187

Prevalence of 2314delG mutation in Spanish patients with Usher syndrome type II (USH2).

M M Beneyto1, J M Cuevas, J M Millán, C Espinós, E Mateu, P González-Cabo, M Baiget, M Doménech, S Bernal, C Ayuso, B García-Sandoval, M J Trujillo, S Borrego, G Antiñolo, M Carballo, C Nájera.   

Abstract

The Usher syndrome (USH) is a group of autosomal recessive diseases characterized by congenital sensorineural hearing loss and retinitis pigmentosa. Three clinically distinct forms of Usher syndrome have so far been recognized and can be distinguished from one another by assessing auditory and vestibular function. Usher syndrome type II (USH2) patients have congenital moderate-to-severe nonprogressive hearing loss, retinitis pigmentosa, and normal vestibular function. Genetic linkage studies have revealed genetic heterogeneity among the three types of USH, with the majority of USH2 families showing linkage to the USH2A locus in 1q41. The USH2A gene (MIM 276901) has been identified: three mutations, 2314delG, 2913delG, and 4353-54delC, were initially reported in USH2A patients, the most frequent of which is the 2314delG mutation. It has been reported that this mutation can give rise to typical and atypical USH2 phenotypes. USH2 cases represent 62% of all USH cases in the Spanish population, and 95% of these cases have provided evidence of linkage to the USH2A locus. In the present study, the three reported mutations were analyzed in 59 Spanish families with a diagnosis of USH type II. The 2314delG was the only mutation identified in our population: it was detected in 25% of families and 16% of USH2 chromosomes analyzed. This study attempts to estimate the prevalence of this common mutation in a homogeneous Spanish population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10916187

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  6 in total

1.  Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II.

Authors:  E Aller; T Jaijo; M Beneyto; C Nájera; S Oltra; C Ayuso; M Baiget; M Carballo; G Antiñolo; D Valverde; F Moreno; C Vilela; D Collado; H Pérez-Garrigues; A Navea; J M Millán
Journal:  J Med Genet       Date:  2006-11       Impact factor: 6.318

Review 2.  Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction.

Authors:  Michelle L Hastings; Timothy A Jones
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

3.  A common ancestral origin of the frequent and widespread 2299delG USH2A mutation.

Authors:  B Dreyer; L Tranebjaerg; V Brox; T Rosenberg; C Möller; M Beneyto; M D Weston; W J Kimberling; C W Cremers; X Z Liu; O Nilssen
Journal:  Am J Hum Genet       Date:  2001-06-08       Impact factor: 11.025

4.  Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II.

Authors:  Denise Yan; Xiaomei Ouyang; D Michael Patterson; Li Lin Du; Samuel G Jacobson; Xue-Zhong Liu
Journal:  J Hum Genet       Date:  2009-10-30       Impact factor: 3.172

5.  Targeted next generation sequencing in Italian patients with Usher syndrome: phenotype-genotype correlations.

Authors:  Chiara M Eandi; Laura Dallorto; Roberta Spinetta; Maria Pia Micieli; Mario Vanzetti; Alessandro Mariottini; Ilaria Passerini; Francesca Torricelli; Camilla Alovisi; Cristiana Marchese
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

6.  Detection of genomic variation by selection of a 9 mb DNA region and high throughput sequencing.

Authors:  Sergey I Nikolaev; Christian Iseli; Andrew J Sharp; Daniel Robyr; Jacques Rougemont; Corinne Gehrig; Laurent Farinelli; Stylianos E Antonarakis
Journal:  PLoS One       Date:  2009-08-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.